Emmanuel Caeymaex
Corporate Officer/Principal bij UCB
Profiel
Emmanuel Caeymaex is currently the Executive VP & Head-Immunology Solutions at UCB SA. Previously, he worked as the Director at Dermira, Inc. in 2017 and as the President at UCB Japan Co. Ltd.
from 2006 to 2011.
He holds a graduate degree from Université Catholique de Louvain and CEMS The Global Alliance in Management Education.
Actieve functies van Emmanuel Caeymaex
| Bedrijven | Functie | Begin |
|---|---|---|
| UCB | Corporate Officer/Principal | 01-03-1994 |
Eerdere bekende functies van Emmanuel Caeymaex
| Bedrijven | Functie | Einde |
|---|---|---|
| DERMIRA, INC. | Director/Board Member | 06-11-2017 |
| UCB Japan Co. Ltd. | President | 01-06-2011 |
Opleiding van Emmanuel Caeymaex
| Université Catholique de Louvain | Graduate Degree |
| CEMS The Global Alliance in Management Education | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| UCB | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| UCB Japan Co. Ltd. | |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
